Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial
Titel:
Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial
Auteur:
Tiseo, Marcello Boni, Luca Ambrosio, Francesca Camerini, Andrea Vitale, Maria Giuseppa Baldini, Editta Cinieri, Saverio Zanelli, Francesca Defraia, Efisio Passalacqua, Rodolfo Crino, Lucio Dazzi, Claudio Tibaldi, Carmelo Turolla, Gianni M. D'Alessandro, Vito Zilembo, Nicoletta Riccardi, Ferdinando Ardizzoni, Andrea